Epigenetics Market Segmentation on the basis of Product, Technology, Application and Region

Global Epigenetics Market is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period. 

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs. 

Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer. 

Technology advancements in the field of epigenetics especially pertaining to the detection of methylation markers related to cancer development is expected to improve usage rates during the forecast period. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene. 

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the report suggest:
·         Epigenetic reagents were the largest market valued at over USD 1.2 billion in 2014 owing to the increasing amount of R&D investments and high consumption rates. Kits are expected to gain rapid growth in demand due to the increasing need of rapid and accurate detection techniques.
·         DNA methylation was the largest technology segment accounting for over 47.0% revenue in 2014. The introduction of technological advancement such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are some factors attributing for its largest share.
·         Oncology was the largest application market, with revenue valued at over USD 2.75 billion. Growing prevalence of cancer with epigenetic modification base and strong product pipeline are some factors attributing to its market position.
·         Non oncology segment is anticipated to register the fastest growth of over 20.0% during the forecast period. The segment is dominated by metabolic diseases owing to, the growing base of population suffering from diabetes and organ failure and increasing prevalence of sedentary lifestyle.
·         North America was observed to be the largest regional epigenetics market accounting for over 38.0% of the overall revenue, due to factors such as the increasing cancer prevalence, increasing amount of funding for R&D, growing collaborations between large pharmaceutical firms for development of improved therapeutics, high patient awareness levels.
·         The Asia Pacific market is estimated to witness lucrative growth over the forecast period owing to, the presence of large prevalence of target diseases and high unmet medical needs
·         Some key players of the epigenetics market include Illumina, Abcam, Diagenode, Thermo Fisher Scientific, Merck, Zymo research, Qiagen, CellCentric Ltd, Chroma Therapeutics Ltd, Eisai Co. Ltd, Novartis International AG, Oncolys Biopharma Inc., Syndax Pharmaceuticals, Inc., Valirx Plc and Sigma-Aldrich Corporation.
·         Extensive R&D initiatives aimed at the development of novel drugs and the presence of strong product pipeline is expected to further boost market growth over the forecast period. 

View all Related Reports from same Category: http://www.grandviewresearch.com/industry/medical-devices 

Grand View Research has segmented the global epigenetics market on the basis of product, technology, application and region:

Epigenetics Product Outlook (Revenue, USD Million, 2015 – 2022)
·         Reagents
·         Kits
·         Instruments
·         Enzymes
·         Services
Epigenetics Technology Outlook (Revenue, USD Million, 2015 – 2022)
·         DNA Methylation
·         Histone Methylation
·         Histone Acetylation
·         Large noncoding RNA
·         MicroRNA Modification
·         Chromatin structures
Epigenetics Application Outlook (Revenue, USD Million, 2015 – 2022)
Oncology
·         Solid Tumors
·         Liquid Tumors
Non Oncology
·         Inflammatory Diseases
·         Metabolic Diseases
·         Infectious Diseases
·         Cardiovascular Diseases
Epigenetics Market Regional Outlook (Revenue, USD Million, 2015 – 2022)
North America
·         U.S.
·         Canada
Europe
·         UK
·         Germany
Asia Pacific
·         Japan
·         China
·         India
Latin America
·         Brazil
·         Mexico
Middle East and Africa (MEA)
·         South Africa
 
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-epigenetics-market 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
For more Information visit us@ www.grandviewresearch.com

Enzymes Market Quantitative Analysis by Market size, estimates, and forecast from 2013 to 2024

Global Enzymes Market is expected to reach USD 17.50 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for enzymes in food & beverage products as they improve quality and eliminate deficiencies in the products is expected to propel industry growth in the near future.

Increasing demand for bioethanol and biodiesel in emerging economies including India, Brazil, and Thailand will augment industry growth over the forecast period. Growing number of government investments along with R&D activities in industrial enzymes will drive demand over the next eight years.

Rising population along with rising living standard will drive processed foods demand, which in turn will stimulate industry expansion. In addition, emerging protein design algorithms, along with growing inexpensive DNA sequencing technology will open new market avenues over the next seven years.

Carbohydrases accounted for 47.7% of the global market share in 2015, dominating the enzymes industry and the segment is expected to show significant growth in light of high usage in animal feed, textile, food & beverages, and pharmaceutical applications. Moreover, mounting usage of artificial sweeteners, prebiotic products, and juices is expected to fuel product demand over the forecast period. 

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/enzymes-industry

Further key findings from the report suggest

• Specialty enzymes are anticipated to witness the fastest growth at a CAGR of 9.2% from 2016 to 2024 on account of increasing awareness regarding therapies for chronic diseases, along with growing incidences of digestive enzyme disorders. Moreover, increasing usage of the ingredient for diagnostic solutions is expected to augment growth. Chemical reactions in research & biotechnology are accelerated by making the use of enzymes. They also optimize the yield of the production processes, which is expected to bolster demand over the forecast period.
• Animal feed is likely to witness significant growth at a CAGR of 9.0% from 2016 to 2024 as a result of mounting demand for swine, bovine, poultry and aquaculture species. Growing global meat production coupled with rising health concern regarding meat quality will augment animal feed demand, which is expected to stimulate industry expansion.
• North America enzymes market was valued at USD 3.59 billion in 2015 and will show high gains in light of favorable government policies along with a robust manufacturing base in the U.S. Growing demand for animal feed and biofuels in the U.S. is expected to drive market size.
• Latin America accounted for 8.3% of the overall enzymes market and will show substantial growth in light of rapid industrialization coupled with increasing biodiesel production in Brazil and Argentina.
• Key industry players include Novozymes, Danisco, Royal DSM, BASF SE, DuPont, Lonza Group, and Advanced Enzymes Technologies Ltd. In January 2014, DuPont launched LAMINEX MaxFlow 4G enzyme, intended for increasing texture, taste and appearance of beer in beverages applications. 

View all related reports from same Category: http://www.grandviewresearch.com/industry/catalysts-and-enzymes 

Grand View Research has segmented the global enzymes market on the basis of type, product, application and region:

Global Enzymes Type Outlook (Revenue, USD Million, 2013 - 2024)

• Industrial enzymes
• Specialty enzymes

Global Enzymes Product Outlook (USD Million, 2013 - 2024)

• Carbohydrase
• Proteases
• Lipases
• Polymerases & nucleases
• Others

Global Industrial Enzymes Application Outlook (Revenue, USD Million; 2012 - 2022)

• Food & Beverages
• Detergents
• Animal Feed
• Textile
• Paper & Pulp
• Nutraceutical
• Personal Care & Cosmetics
• Wastewater

Global Specialty Enzymes Application Outlook (Revenue, USD Million; 2012 - 2022)

• Pharmaceuticals
• Research & biotechnology
• Diagnostics
• Biocatalyst

Global Enzymes Regional Outlook (Revenue, USD Million, 2013 - 2024)
North America

• U.S.
• Mexico
• Canada

Europe

• Germany
• UK
• France

Asia Pacific

• China
• India
• Japan

Latin America

• Brazil

MEA
 
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-enzymes-market 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
For more Information visit us@ www.grandviewresearch.com

Enteral Feeding Formulas Market Analysis 2015 and Forecast up to 2024

Global Enteral Feeding Formulas Market is expected to reach over USD 7.5 billion by 2024, according to a new report by Grand View Research, Inc. Key factors driving growth include increase in geriatric population, rise in chronic diseases, rising preterm births, and increasing demand for home care services. 

The enteral feeding formulas market is expected to witness lucrative growth over the forecast period, owing to a few benefits such as the preservation of gastrointestinal tract structure and its functioning, low-cost alternative to support the patient nutrition, and lowering of rate of infection. 

According to the WHO, an estimated 15 million babies are born prematurely, which accounts for 1 in every 10 babies. Furthermore, nearly 1 million children die every year due to complications of preterm birth. The growing nutritional requirements for neonates, infants, and children are boosting the consumption of various enteral feeding products. Moreover, the children suffering from chronic disease conditions and severe malnutrition are expected to drive the use of specialized formulas over the forecast period. 

Increase in aging population will have a major impact on the enteral feeding formulas market. The ageing population requires more focus to treat chronic diseases like osteoporosis, heart disease, Alzheimer’s disease, and others. According to Administration on Ageing, it is estimated that approximately 80% of people aged 65 and above have at least one chronic illness; as a result, the usage of various enteral feeding formulas is expected to grow rapidly over the forecast period. 

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/enteral-feeding-formulas-market

Further Key Findings from the Study Suggest:

• In 2015, standard formulas dominated the enteral feeding formulas market with a revenue share of over 64.3%. The use of standard formulas from many years is one of the key reasons for the high share. However, the disease-specific formulas segment is expected to have the highest CAGR of 8.6%. The healthcare providers prefer the use of disease-specific formulas to tackle the disease-based nutritional deficiencies in pediatric and adult patients.
• The oncology segment accounted for the maximum share of over 36% in 2015. The diabetic segment is expected to be the fastest growing application with a CAGR of 8.4% over the forecast period.
• North America accounted for the majority share of over 38%, due to growing disease burden, increase in geriatric population, growing number of surgical procedures, increasing awareness about nutritional supplements, and well-developed healthcare networks
• Some key players operating in the market are Abbott Laboratories, Nestle S.A, Danone S.A, Fresenius Kabi AG, B. Braun Melsungen AG, Mead Johnson & Company, LLC. These players face intense competition and therefore, these companies leverage their brand value and sales channel network to increase their market share. 

View all Related Reports from same Category: http://www.grandviewresearch.com/industry/pharmaceuticals 

Grand View Research has segmented the enteral feeding formulas into type, stage, application, end use and region.

Enteral Feeding Formulas Market, by Product (USD Million, 2015 - 2024)

• Standard Formulas
• Disease Specific formulas

Enteral Feeding Formulas Market, by Stage (USD Million, 2015 - 2024)

• Adults
• Pediatric

Enteral feeding Formulas Market, by Application (USD Million, 2015 - 2024)

• Oncology
• Gastroenterology
• Neurology
• Diabetes
• Critical care

Enteral Feeding Formulas Market, by End User (USD Million, 2015 - 2024)

• Hospitals
• Long-term care
• Homecare

Enteral Feeding Formulas Market, by Region, (USD Million, 2012 - 2024)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• Japan
• China

Latin America

• Brazil
• Mexico

MEA

• South Africa

 
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-enteral-feeding-formulas-market 

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
For more Information visit us@ www.grandviewresearch.com

Empty Capsules Market Segmentation on the basis of Product, Therapeutic Application, End User and Region

Global Empty Capsules Market is expected to reach USD 2.57 billion by 2024, according to a new report by Grand View Research, Inc. Key factors responsible for the growth are the increase in the geriatric population, proliferation of pharmaceutical, nutraceutical, and cosmeceutical industries, globally and the upsurge in the consumer preferences for capsules over tablets. 
The rising geriatric population count and the associated chronic conditions are expected to heighten the demand for the production of capsule-centric medications in the pharmaceutical and nutraceutical application areas. Moreover, the benefits associated with capsule consumption, such as ease of swallowing, faster absorption rates, and increased palatability are also expected to contribute significantly to the expansion of the market over the forecast period. 

The mushrooming of the pharmaceutical, nutraceutical, and cosmeceutical industries is expected to serve as a high impact rendering driver for the empty capsules market over the forecast period. 

The nutraceuticals aid in the prevention of certain chronic conditions and hence the consumption of these products has significantly increased over the past few years. For instance, nutraceuticals, such as omega-3 fatty acids, help in the prevention of cardiovascular conditions and the heightened accessibility to these low-cost vitamin supplements has reduced the incidences of vitamin deficiencies. 

In 2015, the gelatin capsules segment accounted for the highest revenue of nearly USD 1,172.3 million. This high revenue share is attributed to the following factors: sufficient availability of gelatin for the production process and the cost-effectiveness of gelatin capsules as compared to non-gelatin capsules, such as Hydroxypropyl methylcellulose (HPMC) capsules and pullulan or starch material capsules. 

However, the non-gelatin capsules segment is expected to emerge as the fastest growing category with a CAGR of 6.9% from 2016 to 2024. With the source of the non-gelatin capsules being vegetarian, the religious and cultural issues experienced in connection with capsules containing animal-derived inactive ingredients can be evaded; this factor is estimated to be primarily responsible for the large consumer base of this market over the forecast period.  

Access for full Detail of Report: http://www.grandviewresearch.com/industry-analysis/empty-capsules-market

Further key findings from the study suggest:

• In 2015, the antibiotic and antibacterial drugs segment generated the largest revenue of USD 453.7 million owing to the surge in prevalence of a range of infectious diseases and chronic conditions worldwide. The vitamins and dietary supplements category is expected to exhibit the fastest growth rate of 7.8% over the forecast period.
• Global efforts to reduce malnutrition and vitamin deficiencies by various social welfare organizations and government agencies are expected to boost the usage rates over the forecast period.
• In 2015, North America dominated the empty capsules market with a revenue share of over 39.6% due to the high disease burden, the access to the latest drugs in this region, and the high consumption rate of nutraceutical and cosmeceutical products in this region. Increase in the geriatric population susceptible to varied conditions and disorders coupled with the burgeoning of various bacterial and viral infections is expected to improve the market penetration of various antibiotics, multivitamin supplements, and other drugs.
• The Asia Pacific region is estimated to grow with the highest CAGR of 7.9% over the forecast period. The increase in healthcare expenditure and the rise in per-capita disposable incomes are expected to improve the overall access to healthcare facilities and medicines across several developing countries in this region. Moreover, the upsurge in the prevalence of infectious diseases and chronic conditions in this region are also expected to positively reinforce the market growth over the forecast period.
• The market dynamics indicate the presence of strong competition amongst the key players, such as Capsugel, Inc., ACG Associated Capsules Pvt. Ltd., JC Biological Technology Co. Ltd, CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc. (Mitsubishi Chemical Holdings Corporation), Patheon, Inc. (Banner Pharmacaps, Inc.), Roxlor LLC, Sunil Healthcare Ltd. (Sunloc Healthcare, Inc.), and Nectar Lifesciences Ltd.
• Furthermore, the increase in the demand for generic drugs and contract manufacturing services is expected to open up new avenues for the market growth over the forecast period. 

View all Related Reports from same Category: http://www.grandviewresearch.com/industry/pharmaceuticals 

Grand View Research has segmented the empty capsules market by product, therapeutic application, end user and region: 

Global empty capsules market, by product (USD Million, 2013 - 2024)

• Gelatin Capsules
• Non-Gelatin capsules

Global empty capsules market by therapeutic application (USD Million, 2013 - 2024)

• Antibiotic and antibacterial drugs
• Vitamin and dietary supplements
• Antacids and antiflatulent preparations,
• Antianemic preparations,
• Anti-inflammatory and anti-rheumatic drugs,
• Cardiac therapy drugs,
• Cough and cold preparations

Global empty capsules market by end-user (USD Million, 2013 - 2024)

• Pharmaceutical industries
• Nutraceutical industries
• Cosmeceutical industries
• Research laboratories

Empty capsules market, by region (USD Million, 2013 - 2024)
North America

• U.S.
• Canada

Europe

• Germany
• UK

Asia Pacific

• Japan
• China

Latin America

• Brazil
• Mexico

MEA

• South Africa

 
Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-empty-capsules-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Disposable Medical Sensors Market Segmentation on the basis of Product, Region, Technology, and Application

Global Disposable Medical Sensors Market is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth.

Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share.

Access for full Detail of Report: http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry

Further key findings from the study suggest:

• Image sensors are expected to be a high growth segment over the forecast period owing to the introduction of technology advancements such as optic fiber technology; low power miniature CMOS image sensors and ZSRL image sensors. These sensors enable medical imaging and endoscopy systems to function with accuracy and therefore, help in effective diagnostic and therapeutic interventions.
• Disposable medical sensors based diagnostic applications dominated the overall market with revenue estimated at over 1,700.0 million in 2013. Increasing demand for point of care diagnoses such as i-stats, biosensors for the diagnosis and monitoring of glucose levels in emergency rooms is expected to drive the market during the forecast period.
• North America dominated the global market, accounting for over 35% of total revenue in 2013 on account of the presence of sophisticated healthcare infrastructure and growing R&D spending for the development of miniaturized and convenient medical sensors.
• Asia Pacific disposable medical sensors market is expected to grow at a CAGR of over 11.0% over the next six years, which is the highest among all regions. Increasing demand for home healthcare biosensors and improving healthcare infrastructure in emerging countries such as China and India are some factors contributing to its rapid growth.
• Some key players of disposable medical sensors include Honeywell International, Inc, Covidien Plc, STMicroelectronics, Given Imaging, Inc., GE Healthcare, Medtronic, Freescale Semiconductor, Inc., Philips Healthcare, Analog Devices, Smiths Medical, Measurement Specialties and Sensirion AG.

View all Related Reports from Same Category: http://www.grandviewresearch.com/industry/medical-devices 

For the purpose of this study, Grand View Research has segmented the disposable medical sensors market on the basis of product, technology, application and region:

    • Global Disposable Medical Sensors Product Outlook (Revenue, USD Million, 2012 – 2020)
            • Wearable sensors
            • Implantable sensors
            • Invasive sensors
            • Ingestible sensors
            • Strip sensors
    • Global Disposable Medical Sensors Technology Outlook (Revenue, USD Million, 2012 – 2020)
            • Temperature sensors
            • Pressure sensors
            • Image sensors
            • Biosensors
            • Accelerometers
            • Others
    • Global Disposable Medical Sensors Application Outlook (Revenue, USD Million, 2012 – 2020)
            • Diagnostic
            • Patient monitoring
            • Therapeutic
    • Disposable Medical Sensors Regional Outlook (Revenue, USD Million, 2012 – 2020)
            • North America
            • Europe
            • Asia Pacific
            • RoW


Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Bioresorbable Polymer Market report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025

Global Bioresorbable Polymer Market is anticipated to reach USD 2.26 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand in the medical sector, owing to its hydrolytically degrading property in the body is projected to increase the global market growth. 

The increasing health awareness, improving healthcare facilities worldwide and growing surgery procedures across the globe will have a positive impact on the Bioresorbable polymers industry growth in the overcoming years.

The increasing product demand for drug delivery application is another key factor for market development over the forecast period. The harmless decomposition and its chemically neutral nature in the body make them suitable for drug delivery segment.

The PLA-based product demand exceeded 89 tons in 2015, which is projected to remain as the largest and fastest growing segment over the upcoming years. The PLA market is growing dramatically in the pharmaceutical sector owing to its distinctive feature of being biodegradable and biocompatible.

Access for full Detail of Report: http://www.grandviewresearch.com/industry-analysis/bioresorbable-polymers-market

Further Key Findings from the Study Suggest:

• The global Bioresorbable polymers demand was over 298 tons in 2015 and is expected to grow at an estimated CAGR of 14.3% over the projected period
• The PCL-based product market accounted for over 13% of the total revenue in 2015
• Orthopedics was the leading application segment with demand exceeding 45% in 2015
• The Bioresorbable polymer market in drug delivery application is estimated to have the highest growth at a CAGR of over 14% from 2016 to 2025
• The U.S. polyglycolic acid product market generated revenue worth of USD 31.5 million in 2015 and is expected to reach a total revenue of over USD 110 million by 2025
• Polysaccharides demand in Europe is estimated to exceed a total revenue of USD 470 million by the end of forecast period
• Factors such as changing consumption patterns, technological advancements, and rising government initiatives, are anticipated to influence the market in the overcoming years
• Influential companies operating in this market include Carbion NV, Evonik Industries AG, Poly-Med, Inc., Foster Corporation and KLS Martin Group
• Evonik and Carbion dominated the global market together accounting for over 50% of the total revenue in 2015

View all related Reports from Same Category: http://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers 

Grand View Research has segmented the Bioresorbable polymer market on the basis of product, application and region:

Bioresorbable Polymers Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Polysaccharides
• Proteins
• Polylactic acid
• Polyglycolic acid
• Polycaprolactone
• Others

Bioresorbable Polymers Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Drug Delivery
• Orthopedics
• Others

Bioresorbable Polymers Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
North America

• U.S
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Italy

Asia Pacific

• China
• India
• Japan
• Middle East and Africa
• Central & South America

Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-bioresorbable-polymers-market 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com

Flavonoids Market Summary 2014-2025 by Emerging Trends, Market Segmentation, and Scope

Global Flavonoids Market is expected to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Changing consumer lifestyles and rising demand for beauty & health supplements are expected to propel flavonoids consumption over the forecast period.

Developed countries such as Denmark, France, Australia, Belgium, Norway, and the U.S. are characterized by high cancer prevalence. Application of flavonoid as an anti-cancer drug is expected to be the major factor driving growth in these countries, over the forecast period.

Rising demand for convenience food products has increased utilization of flavonoids in functional food. Moreover, smoothing and antioxidant properties allow it to be used in the cosmetics industry for skin care applications. These are also being used to develop drugs for the treatment of various other diseases including diabetes and cardiovascular problems, prevailing worldwide, further increasing demand.

Access for full detail of Report: http://www.grandviewresearch.com/industry-analysis/flavonoids-market

Further key findings from the report suggest:

• Anthocyanins were the most commonly consumed flavonoids in 2015 with a market share of over 40% in 2015. Growing demand from the nutraceuticals and functional food segment is expected to drive this market over the forecast period.
• The functional beverages segment is expected to grow at a CAGR of over 12% from 2016 to 2025, in terms of revenue. Antioxidant properties of this product are now being introduced in non-alcoholic beverages including soft drinks, nutraceutical drinks, and energy drinks, propelling demand in this application.
• The flavonoids market in functional foods was valued over USD 130 million in 2015 on account of anti-diabetic and anti-carcinogenic properties which are expected to increase their consumption in nutraceutical and functional food products.
• North America demand is expected to rise on account of rapid economic development with the U.S. and Canada being major nutraceutical markets in this region, triggering growth over the forecast period.
• The market in Central & South America is projected to grow at the second highest CAGR of over 9% from 2016 to 2025, driven by growing demand from emerging economies such as Brazil and Argentina.
• In January 2016, Cayman Chemical Company, one of the leading manufacturers of this product, acquired Biomol GmbH, a Germany-based distributor of research reagent chemicals. This acquisition helped the company strengthen its position in Europe.

View all related Reports from same Category: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements 

Grand View Research has segmented the global flavonoids market on the basis of product, application and region:

Global Flavonoids Product Outlook (Volume, Tons: Revenue, USD Million, 2014 - 2025)

• Anthocyanins
• Flavones
• Anthoxanthins
• Others

Global Flavonoids Application Outlook (Volume, Tons: Revenue, USD Million, 2014 - 2025)

• Functional beverages
• Functional food
• Dietary supplements
• Others

Global Flavonoids Regional Outlook (Volume, Tons: Revenue, USD Million, 2014 - 2025)
North America

• U.S.

Europe

• Germany

Asia Pacific

• China

Latin America

• Brazil

Middle East & Africa
 
Browse Press Release of this Report@ http://www.grandviewresearch.com/press-release/global-flavonoids-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us@ www.grandviewresearch.com